EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 7, 2026
EV Biologics Market Cap
EV Biologics has a market cap or net worth of $1.02 thousand as of October 23, 2026. It is the 52,474th most valuable company in the world and the 8,427th biggest in the United States. Its market cap has decreased by 99.88% in one year.
Market Cap
1.02K
Enterprise Value
n/a
Revenue
9.47M
Global Rank
Country Rank
#8,427 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since June 29, 2015, EV Biologics's market cap has decreased from 70.39M to 1.02K, a decrease of -100.00%. That is a compound annual growth rate of -62.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 1.02K | -99.88% |
| Dec 31, 2025 | 829.28K | -15.08% |
| Dec 31, 2024 | 976.52K | -90.45% |
| Dec 20, 2023 | 10.23M | -56.18% |
| Dec 28, 2022 | 23.33M | 109.88% |
| Dec 31, 2021 | 11.12M | -83.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RegeneRx Biopharmaceuticals | 1.66K |
| Affimed | 1.64K |
| ZIM Corporation | 1.63K |
| DNAPrint Genomics | 1.30K |
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| Virpax Pharmaceuticals | 994.00 |
| American Oriental Bioengineering | 949.00 |